Ten things the hematologist wants you to know about CAR-T cells

Intensive Care Med. 2020 Jun;46(6):1243-1245. doi: 10.1007/s00134-020-06002-9. Epub 2020 Mar 30.

Boris Böll^{1

2}, Marion Subklewe^{3

4

5}, Michael von Bergwelt-Baildon^{6

3

4

5

7}

¹ Department I of Internal Medicine, Hematology-Oncology, Intensive Care Medicine, Center of Integrated Oncology Cologne-Bonn, University Hospital of Cologne, Cologne, Germany. boris.boell@uk-koeln.de.
² Working Party on Intensive Care Medicine in Hematologic and Oncologic Patients (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO), Berlin, Germany. boris.boell@uk-koeln.de.
³ Department of Medicine III, University Hospital, LMU, Munich, Germany.
⁴ Comprehensive Cancer Center Munich, Munich, Germany.
⁵ German Center for Translational Cancer Research (DKTK), Munich, Germany.
⁶ Working Party on Intensive Care Medicine in Hematologic and Oncologic Patients (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO), Berlin, Germany.
⁷ Bavarian Center for Cancer Research (BZKF), Munich, Germany.

No abstract available

MeSH terms